Ligand Pharmaceuticals - Biopharma's Technology and Capital Partner
Ligand invests in the clinical development and commercialization of high-value medicines. We manage one of the largest and most diverse portfolios of biopharmaceutical royalties in the industry, with …
Ligand Pharmaceuticals Incorporated - Investor Relations
Nov 7, 2025 · Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value …
Ligand Pharmaceuticals Incorporated - Stock Info
Dec 11, 2023 · All 3m NASDAQ:LGND News Releases Oct 20 Oct 27 Nov 3 Nov 10 Nov 17 Nov 24 Dec 1 Dec 8 Dec 15 Dec 22 Dec 29 Jan 5 Jan 12 2021 2022 2023 2024 2025 2026 168 180 192 204 ...
Royalty Portfolio - Ligand Pharmaceuticals
Attractive programs with high clinical value. Today, Ligand manages one of the largest and most diverse portfolios of biopharmaceutical royalties in the industry, with more than 100 partnered commercial …
Ligand Reports First Quarter 2025 Financial Results
May 8, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …
About Us - Ligand Pharmaceuticals
Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value programs that can …
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
Dec 9, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …
Ligand Subsidiary Pelthos Therapeutics to Combine with Channel …
Apr 17, 2025 · Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand does this by providing financing, …
Financials - Quarterly Results - Ligand Pharmaceuticals
Ligand does this by providing financing, licensing our technologies or both. Our business model seeks to generate value for stockholders by creating a diversified portfolio of biotech and pharmaceutical …
Team - Ligand Pharmaceuticals
He joined Ligand from General Inception, where he served as Academic Innovations and Partnerships Lead spearheading efforts on new company formation and investment in therapeutics, synthetic …